Press Releases
Allergan plc announces data at ASM Microbe Highlight In Vitro Antimicrobial Activity of AVYCAZ
Allergan plc committed to developing new treatment options for infectious diseases, today presented new data highlighting the in vitro activity of AVYCAZ® against several...
Press Releases
Medipak Systems Open House at the new premises of Dividella AG
Dividella AG, a Medipak Systems company, welcomed guests to the two-day pharma event in its new premises in Grabs, Switzerland. As...
Press Releases
Quotient Clinical hosts formulation development and drug delivery seminar series
Quotient Clinical, the Translational Pharmaceutics company, is holding a series of formulation development and drug delivery seminars this June and July. ...
News
7 th Edition of the Innovation Days: The must Partnering event in the Life Sciences
The Innovation Days are a unique international event focused on promoting innovation in the field of Life Sciences . For its 7th edition ,...
News
Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625
Shire plc announced that the U.S. FDA has granted Breakthrough Therapy Designation for two investigational products for rare diseases: SHP621 (budesonide oral suspension, or...
Techno Trends
Merck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif® (interferon beta-1a) Agreement provides Merck with exclusive license to...
Press Releases
FDA Accepted Charleston Laboratories, Inc. and Daiichi Sankyo’s New Drug Application (NDA) for CL-108
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. announced that the U.S. FDA has accepted for review the New Drug Application (NDA) for CL-108 for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read